BioWorld

Jan. 18, 2002

View Archived Issues

Bush’s Bioethics Panel Meets For First Time, Starts On Cloning

Read More

Lactase Enzyme Mutant Gene Against Lactose Intolerance Discovered In Intestinal Cells

Read More

Maxim Begins Ceplene Phase III With Liver Metastases Patients

Read More

Holiday Notice

Read More

Other News To Note

Read More

Rigel Raises $31.5M To Move First Product Into Clinic In 2002

Read More

President’s Council on Bioethics

Read More

Cubist Meeting With FDA After Cidecin Fails To Meet Endpoint

Cubist Pharmaceuticals Inc. said its investigational antibiotic, Cidecin, failed to meet its primary endpoint in the first of two pivotal Phase III trials for community-acquired pneumonia. Read More